All Posts

The way pharma and biotech companies track their competitors is changing fast. We are moving past basic AI text generators and into a world of autonomous AI agents. These tools can scan huge patent portfolios, track messy clinical trial updates, and predict what rivals will do next in a matter of seconds. This shift is happening right as multi-billion-dollar biologics approach the loss of their patent protection, making the race for information tighter than ever.

Over the last month, highly motivated competitors from all over the world arrived in North America to compete for arguably the most coveted sports prize of all, the FIFA World Cup. It is not hard to see the metaphor between competing at the top level in a global sport and other types of organisation seeking to "win" by creating long-term growth and exploiting new global markets.

Everyone has access to the same secondary data now. That is the part most companies have not fully reckoned with. The analyst reports, the public filings, the press releases, the review-site scrapes, the LinkedIn job postings, the earnings call transcripts. It is all sitting there, and your competitors are pulling from the exact same well you are. AI has made that well easier to draw from than ever. It has not made the water any deeper.